Regulation Of US Supplement Industry Needs ‘Really Hard Look’ – FDA's Woodcock

Acting commissioner's comment on supplement industry regulation was her most definitive statement about the agency’s work in consumer health sector at CHPA's regulatory conference. Pandemic, she says, heightened consumer interest in self-care along with demand for OTC drugs and supplements.

• Source: Alamy

It’s known that the US Food and Drug Administration needs more information to determine whether hemp-derived cannabinoids are safe for dietary supplements. It also should be known, says acting Commissioner Janet Woodcock, that the agency needs to evaluate its oversight of all supplement manufacturing and marketing.

Woodcock’s comment on the FDA’s regulation of the vitamin, mineral and supplement product industry was her most definite statement about...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Regulation

More from Policy & Regulation